The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Biofunctional Peptide-Global Market Insights and Sales Trends 2024
Synopsis
The global Biofunctional Peptide market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Biofunctional Peptide in various end use industries. The expanding demands from the Food and Beverages, Cosmetics and Others,, are propelling Biofunctional Peptide market. Animal, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Vegetal segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Biofunctional Peptide market, driven by demand from China, the second largest economy with some signs of stabilising, the Biofunctional Peptide market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Biofunctional Peptide, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Biofunctional Peptide market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Biofunctional Peptide market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Biofunctional Peptide sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Biofunctional Peptide covered in this report include American Peptide Company Inc., Phermpep Co. Ltd., ALEXIS Corporation, Merck KGaA, Promega Corporation, Advanced Bioconcept Company, Arlak Biotech, WN Pharmaceuticals Ltd. and Anaspec Inc., etc.
The global Biofunctional Peptide market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
American Peptide Company Inc.
Phermpep Co. Ltd.
ALEXIS Corporation
Merck KGaA
Promega Corporation
Advanced Bioconcept Company
Arlak Biotech
WN Pharmaceuticals Ltd.
Anaspec Inc.
Thermo Fisher Scientific
Seagarden AS
Novo Nordisk A/S
Global Biofunctional Peptide market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Biofunctional Peptide market, Segment by Type:
Animal
Vegetal
Global Biofunctional Peptide market, by Application
Food and Beverages
Cosmetics
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Biofunctional Peptide manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Biofunctional Peptide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
The global Biofunctional Peptide market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Biofunctional Peptide in various end use industries. The expanding demands from the Food and Beverages, Cosmetics and Others,, are propelling Biofunctional Peptide market. Animal, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Vegetal segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Biofunctional Peptide market, driven by demand from China, the second largest economy with some signs of stabilising, the Biofunctional Peptide market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Biofunctional Peptide, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Biofunctional Peptide market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Biofunctional Peptide market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Biofunctional Peptide sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Biofunctional Peptide covered in this report include American Peptide Company Inc., Phermpep Co. Ltd., ALEXIS Corporation, Merck KGaA, Promega Corporation, Advanced Bioconcept Company, Arlak Biotech, WN Pharmaceuticals Ltd. and Anaspec Inc., etc.
The global Biofunctional Peptide market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
American Peptide Company Inc.
Phermpep Co. Ltd.
ALEXIS Corporation
Merck KGaA
Promega Corporation
Advanced Bioconcept Company
Arlak Biotech
WN Pharmaceuticals Ltd.
Anaspec Inc.
Thermo Fisher Scientific
Seagarden AS
Novo Nordisk A/S
Global Biofunctional Peptide market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Biofunctional Peptide market, Segment by Type:
Animal
Vegetal
Global Biofunctional Peptide market, by Application
Food and Beverages
Cosmetics
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Biofunctional Peptide manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Biofunctional Peptide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Biofunctional Peptide Market Overview
1.1 Biofunctional Peptide Product Overview
1.2 Biofunctional Peptide Market Segment by Type
1.2.1 Animal
1.2.2 Vegetal
1.3 Global Biofunctional Peptide Market Size by Type
1.3.1 Global Biofunctional Peptide Market Size Overview by Type (2018-2029)
1.3.2 Global Biofunctional Peptide Historic Market Size Review by Type (2018-2023)
1.3.3 Global Biofunctional Peptide Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Biofunctional Peptide Sales Breakdown by Type (2018-2023)
1.4.2 Europe Biofunctional Peptide Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Biofunctional Peptide Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Biofunctional Peptide Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Biofunctional Peptide Sales Breakdown by Type (2018-2023)
2 Global Biofunctional Peptide Market Competition by Company
2.1 Global Top Players by Biofunctional Peptide Sales (2018-2023)
2.2 Global Top Players by Biofunctional Peptide Revenue (2018-2023)
2.3 Global Top Players by Biofunctional Peptide Price (2018-2023)
2.4 Global Top Manufacturers Biofunctional Peptide Manufacturing Base Distribution, Sales Area, Product Type
2.5 Biofunctional Peptide Market Competitive Situation and Trends
2.5.1 Biofunctional Peptide Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Biofunctional Peptide Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Biofunctional Peptide as of 2022)
2.7 Date of Key Manufacturers Enter into Biofunctional Peptide Market
2.8 Key Manufacturers Biofunctional Peptide Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Biofunctional Peptide Status and Outlook by Region
3.1 Global Biofunctional Peptide Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Biofunctional Peptide Historic Market Size by Region
3.2.1 Global Biofunctional Peptide Sales in Volume by Region (2018-2023)
3.2.2 Global Biofunctional Peptide Sales in Value by Region (2018-2023)
3.2.3 Global Biofunctional Peptide Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Biofunctional Peptide Forecasted Market Size by Region
3.3.1 Global Biofunctional Peptide Sales in Volume by Region (2024-2029)
3.3.2 Global Biofunctional Peptide Sales in Value by Region (2024-2029)
3.3.3 Global Biofunctional Peptide Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Biofunctional Peptide by Application
4.1 Biofunctional Peptide Market Segment by Application
4.1.1 Food and Beverages
4.1.2 Cosmetics
4.1.3 Others
4.2 Global Biofunctional Peptide Market Size by Application
4.2.1 Global Biofunctional Peptide Market Size Overview by Application (2018-2029)
4.2.2 Global Biofunctional Peptide Historic Market Size Review by Application (2018-2023)
4.2.3 Global Biofunctional Peptide Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Biofunctional Peptide Sales Breakdown by Application (2018-2023)
4.3.2 Europe Biofunctional Peptide Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Biofunctional Peptide Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Biofunctional Peptide Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Biofunctional Peptide Sales Breakdown by Application (2018-2023)
5 North America Biofunctional Peptide by Country
5.1 North America Biofunctional Peptide Historic Market Size by Country
5.1.1 North America Biofunctional Peptide Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Biofunctional Peptide Sales in Volume by Country (2018-2023)
5.1.3 North America Biofunctional Peptide Sales in Value by Country (2018-2023)
5.2 North America Biofunctional Peptide Forecasted Market Size by Country
5.2.1 North America Biofunctional Peptide Sales in Volume by Country (2024-2029)
5.2.2 North America Biofunctional Peptide Sales in Value by Country (2024-2029)
6 Europe Biofunctional Peptide by Country
6.1 Europe Biofunctional Peptide Historic Market Size by Country
6.1.1 Europe Biofunctional Peptide Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Biofunctional Peptide Sales in Volume by Country (2018-2023)
6.1.3 Europe Biofunctional Peptide Sales in Value by Country (2018-2023)
6.2 Europe Biofunctional Peptide Forecasted Market Size by Country
6.2.1 Europe Biofunctional Peptide Sales in Volume by Country (2024-2029)
6.2.2 Europe Biofunctional Peptide Sales in Value by Country (2024-2029)
7 Asia-Pacific Biofunctional Peptide by Region
7.1 Asia-Pacific Biofunctional Peptide Historic Market Size by Region
7.1.1 Asia-Pacific Biofunctional Peptide Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Biofunctional Peptide Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Biofunctional Peptide Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Biofunctional Peptide Forecasted Market Size by Region
7.2.1 Asia-Pacific Biofunctional Peptide Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Biofunctional Peptide Sales in Value by Region (2024-2029)
8 Latin America Biofunctional Peptide by Country
8.1 Latin America Biofunctional Peptide Historic Market Size by Country
8.1.1 Latin America Biofunctional Peptide Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Biofunctional Peptide Sales in Volume by Country (2018-2023)
8.1.3 Latin America Biofunctional Peptide Sales in Value by Country (2018-2023)
8.2 Latin America Biofunctional Peptide Forecasted Market Size by Country
8.2.1 Latin America Biofunctional Peptide Sales in Volume by Country (2024-2029)
8.2.2 Latin America Biofunctional Peptide Sales in Value by Country (2024-2029)
9 Middle East and Africa Biofunctional Peptide by Country
9.1 Middle East and Africa Biofunctional Peptide Historic Market Size by Country
9.1.1 Middle East and Africa Biofunctional Peptide Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Biofunctional Peptide Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Biofunctional Peptide Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Biofunctional Peptide Forecasted Market Size by Country
9.2.1 Middle East and Africa Biofunctional Peptide Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Biofunctional Peptide Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 American Peptide Company Inc.
10.1.1 American Peptide Company Inc. Company Information
10.1.2 American Peptide Company Inc. Introduction and Business Overview
10.1.3 American Peptide Company Inc. Biofunctional Peptide Sales, Revenue and Gross Margin (2018-2023)
10.1.4 American Peptide Company Inc. Biofunctional Peptide Products Offered
10.1.5 American Peptide Company Inc. Recent Development
10.2 Phermpep Co. Ltd.
10.2.1 Phermpep Co. Ltd. Company Information
10.2.2 Phermpep Co. Ltd. Introduction and Business Overview
10.2.3 Phermpep Co. Ltd. Biofunctional Peptide Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Phermpep Co. Ltd. Biofunctional Peptide Products Offered
10.2.5 Phermpep Co. Ltd. Recent Development
10.3 ALEXIS Corporation
10.3.1 ALEXIS Corporation Company Information
10.3.2 ALEXIS Corporation Introduction and Business Overview
10.3.3 ALEXIS Corporation Biofunctional Peptide Sales, Revenue and Gross Margin (2018-2023)
10.3.4 ALEXIS Corporation Biofunctional Peptide Products Offered
10.3.5 ALEXIS Corporation Recent Development
10.4 Merck KGaA
10.4.1 Merck KGaA Company Information
10.4.2 Merck KGaA Introduction and Business Overview
10.4.3 Merck KGaA Biofunctional Peptide Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Merck KGaA Biofunctional Peptide Products Offered
10.4.5 Merck KGaA Recent Development
10.5 Promega Corporation
10.5.1 Promega Corporation Company Information
10.5.2 Promega Corporation Introduction and Business Overview
10.5.3 Promega Corporation Biofunctional Peptide Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Promega Corporation Biofunctional Peptide Products Offered
10.5.5 Promega Corporation Recent Development
10.6 Advanced Bioconcept Company
10.6.1 Advanced Bioconcept Company Company Information
10.6.2 Advanced Bioconcept Company Introduction and Business Overview
10.6.3 Advanced Bioconcept Company Biofunctional Peptide Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Advanced Bioconcept Company Biofunctional Peptide Products Offered
10.6.5 Advanced Bioconcept Company Recent Development
10.7 Arlak Biotech
10.7.1 Arlak Biotech Company Information
10.7.2 Arlak Biotech Introduction and Business Overview
10.7.3 Arlak Biotech Biofunctional Peptide Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Arlak Biotech Biofunctional Peptide Products Offered
10.7.5 Arlak Biotech Recent Development
10.8 WN Pharmaceuticals Ltd.
10.8.1 WN Pharmaceuticals Ltd. Company Information
10.8.2 WN Pharmaceuticals Ltd. Introduction and Business Overview
10.8.3 WN Pharmaceuticals Ltd. Biofunctional Peptide Sales, Revenue and Gross Margin (2018-2023)
10.8.4 WN Pharmaceuticals Ltd. Biofunctional Peptide Products Offered
10.8.5 WN Pharmaceuticals Ltd. Recent Development
10.9 Anaspec Inc.
10.9.1 Anaspec Inc. Company Information
10.9.2 Anaspec Inc. Introduction and Business Overview
10.9.3 Anaspec Inc. Biofunctional Peptide Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Anaspec Inc. Biofunctional Peptide Products Offered
10.9.5 Anaspec Inc. Recent Development
10.10 Thermo Fisher Scientific
10.10.1 Thermo Fisher Scientific Company Information
10.10.2 Thermo Fisher Scientific Introduction and Business Overview
10.10.3 Thermo Fisher Scientific Biofunctional Peptide Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Thermo Fisher Scientific Biofunctional Peptide Products Offered
10.10.5 Thermo Fisher Scientific Recent Development
10.11 Seagarden AS
10.11.1 Seagarden AS Company Information
10.11.2 Seagarden AS Introduction and Business Overview
10.11.3 Seagarden AS Biofunctional Peptide Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Seagarden AS Biofunctional Peptide Products Offered
10.11.5 Seagarden AS Recent Development
10.12 Novo Nordisk A/S
10.12.1 Novo Nordisk A/S Company Information
10.12.2 Novo Nordisk A/S Introduction and Business Overview
10.12.3 Novo Nordisk A/S Biofunctional Peptide Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Novo Nordisk A/S Biofunctional Peptide Products Offered
10.12.5 Novo Nordisk A/S Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Biofunctional Peptide Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Biofunctional Peptide Industrial Chain Analysis
11.4 Biofunctional Peptide Market Dynamics
11.4.1 Biofunctional Peptide Industry Trends
11.4.2 Biofunctional Peptide Market Drivers
11.4.3 Biofunctional Peptide Market Challenges
11.4.4 Biofunctional Peptide Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Biofunctional Peptide Distributors
12.3 Biofunctional Peptide Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
